Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome (RESTORE Study)
Details
Age
Child to Adult
Eligibility
To be eligible: Female sex Age 12-35 years old Suspected or Diagnosed PCOS Periods more than 5 weeks apart Not desiring pregnancy in the next 18 months Not using hormonal birth control Struggle with weight Youth BMI >95th percentile Adults BMI >/=27 kg/m2 Contact: PCOSresearch@cuanschutz.edu
Type of Study
Treatment
Locations
Childrens Hospital Colorado
Outpatient CTRC
Principal Investigator
Melanie Green, MD, PhD
Study ID
Protocol Number: 21-4941
More information available at ClinicalTrials.gov: NCT05819853
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers